GT Biopharma Reports Q4 Results

Seeking AlphaMar 26 16:17

Recap: GT Biopharma Q4 Earnings

GT Biopharma (NASDAQ:GTBP) reported its Q4 earnings results on Tuesday, March 26, 2024 at 05:00 PM.Here's what investors need to know about the announcement.EarningsGT Biopharma beat estimated earning

BenzingaMar 26 16:15

GT Biopharma Q4 EPS $(2.14) Beats $(2.70) Estimate

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(2.14) per share which beat the analyst consensus estimate of $(2.70) by 20.74 percent. This is a 60.37 percent increase over losses of $(5.40)

BenzingaMar 26 16:14

GT Biopharma Q4 Net Loss $(2.96)M Vs $(5.58)M Loss Last Year; Cash Of ~$14M As Of December 31, 2023, Provides Sufficient Runway To Fund Operations Into 2025

GT Biopharma Q4 Net Loss $(2.96)M Vs $(5.58)M Loss Last Year; Cash Of ~$14M As Of December 31, 2023, Provides Sufficient Runway To Fund Operations Into 2025

BenzingaMar 26 16:04

GT Biopharma 4Q R&D Expenses $1.4M >GTBP

GT Biopharma 4Q R&D Expenses $1.4M >GTBP

Dow JonesMar 26 16:02

GT Biopharma 4Q Loss $3M >GTBP

GT Biopharma 4Q Loss $3M >GTBP

Dow JonesMar 26 16:02